Respiratory Syncytial Virus in Older Adults: Setting the Foundation

New reports from ECCMID 2022 shed light on the disease burden of RSV in older adults, as well as the impact of the COVID-19 pandemic on seasonal trends in RSV.

Ting Shi, PhD Released: May 19, 2022

There has never been a more promising time in the field of RSV for older adults than now, with the exciting preventive therapies on the horizon.

Dexter James Wiseman, MD Released: December 29, 2022

A new vaccine candidate for prevention of RSV in older adults was added to the EMA’s PRIME scheme. Here’s my summary of the key clinical trial information.

Ting Shi, PhD Released: August 18, 2022

Read my commentary on how RSV can have a detrimental impact on quality of life, especially in older adults.

Zhuxin Mao, PhD Released: January 30, 2023